Saved in:
| Main Authors: | Madhumita Rao, Robert L. Page, Emily Sartain |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1111/ctr.70147 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
by: Vaisak O. Nair, et al.
Published: (2025)
by: Vaisak O. Nair, et al.
Published: (2025)
Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients
by: John‐Anthony Coppola, et al.
Published: (2025)
by: John‐Anthony Coppola, et al.
Published: (2025)
Effects of Nighttime Procurement and Transplantation on Outcomes Following Heart Transplantation
by: Yeahwa Hong, et al.
Published: (2025)
by: Yeahwa Hong, et al.
Published: (2025)
Impact of the Distance Between Patient Residency and Heart Transplant Center on Outcomes After Heart Transplantation
by: Waleed Ahmad, et al.
Published: (2024)
by: Waleed Ahmad, et al.
Published: (2024)
Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
by: Suneri J. Amin, et al.
Published: (2025)
by: Suneri J. Amin, et al.
Published: (2025)
Impact of Age of Heart Transplant Program on Patient Survival and Post‐Transplant Outcomes
by: David T. Majure, et al.
Published: (2024)
by: David T. Majure, et al.
Published: (2024)
De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
by: Hanna L. Kleiboeker, et al.
Published: (2025)
by: Hanna L. Kleiboeker, et al.
Published: (2025)
Alternative Measures of Body Composition and Outcomes Following Heart Transplant
by: Ana Lanier, et al.
Published: (2026)
by: Ana Lanier, et al.
Published: (2026)
Impact of Heart Failure Etiology on Waitlist Mortality in Heart Transplant Candidates Supported With Extracorporeal Membrane Oxygenation
by: Manuj M. Shah, et al.
Published: (2024)
by: Manuj M. Shah, et al.
Published: (2024)
Long‐Term Outcomes Among Lung Transplant Recipients With High‐Risk Cytomegalovirus Mismatch Managed With a Multimodality Regimen
by: Natasha Banga, et al.
Published: (2025)
by: Natasha Banga, et al.
Published: (2025)
Contemporary Immunosuppression Management and 1‐Year Outcomes in Dual Organ Heart Transplantation
by: Xinyi Huang, et al.
Published: (2024)
by: Xinyi Huang, et al.
Published: (2024)
Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes
by: Masaki Tsuji, et al.
Published: (2025)
by: Masaki Tsuji, et al.
Published: (2025)
Assessing the Role of Primary Heart Failure Etiology on Cardiac Transplant Outcomes
by: Ahad Firoz, et al.
Published: (2024)
by: Ahad Firoz, et al.
Published: (2024)
Risk Factors and Outcomes of Reintubation Following Combined Heart‐Lung Transplantation
by: Ye In Christopher Kwon, et al.
Published: (2026)
by: Ye In Christopher Kwon, et al.
Published: (2026)
Decreasing the Risk of Early Sub‐Therapeutic Tacrolimus Troughs on Short‐Term Outcomes in Low‐Moderate Risk Kidney Transplant Recipients Receiving Rabbit Anti‐Thymocyte Globulin Induction
by: Xinqi Liu, et al.
Published: (2025)
by: Xinqi Liu, et al.
Published: (2025)
Sex Differences in Incidence and Outcomes of New‐Onset Post‐Transplant Diabetes Mellitus After Heart Transplantation
by: Alice Chung, et al.
Published: (2025)
by: Alice Chung, et al.
Published: (2025)
Perioperative Timing Impacts Renal Graft Outcomes in Simultaneous Heart‐Kidney Transplantation
by: Brendan P. Lovasik, et al.
Published: (2025)
by: Brendan P. Lovasik, et al.
Published: (2025)
Evolving Trends and Impact of Waitlist Transfusion on Recipient Outcomes Following Heart Transplantation
by: Yeahwa Hong, et al.
Published: (2024)
by: Yeahwa Hong, et al.
Published: (2024)
Clinical Utility of Donor‐Derived Cell‐Free DNA in Heart Transplant Recipients With Multi‐Organ Transplants
by: Cathrine M. Moeller, et al.
Published: (2024)
by: Cathrine M. Moeller, et al.
Published: (2024)
Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
by: Lemuel R. Non, et al.
Published: (2024)
by: Lemuel R. Non, et al.
Published: (2024)
Cognitive Function Among Heart Transplant Recipients Before and After Intravenous Iron Supplement for Iron Deficiency: Results From a Randomized, Placebo‐Controlled, Double‐Blind Treatment Trial
by: Britta S. Bürker, et al.
Published: (2025)
by: Britta S. Bürker, et al.
Published: (2025)
Heart Transplantation for Amyloid Cardiomyopathy Has Comparable Outcomes With Other Etiologies: The UNOS Database
by: Nicholas Steudel, et al.
Published: (2025)
by: Nicholas Steudel, et al.
Published: (2025)
Outcomes of Donor‐Recipient Size Mismatch in Donation After Circulatory Death Heart Transplantation
by: Iris Feng, et al.
Published: (2025)
by: Iris Feng, et al.
Published: (2025)
Evolving Long‐Term Outcomes of Heart Transplantation Using COVID‐19 Positive Donors
by: Ye In Christopher Kwon, et al.
Published: (2026)
by: Ye In Christopher Kwon, et al.
Published: (2026)
Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
by: Abdallah Mughrabi, et al.
Published: (2026)
by: Abdallah Mughrabi, et al.
Published: (2026)
Clinical Characteristics and Outcomes Associated With Immediate Versus Delayed Presentation of Severe Primary Graft Dysfunction After Heart Transplantation: Does Timing Matter?
by: Yosef Manla, et al.
Published: (2025)
by: Yosef Manla, et al.
Published: (2025)
De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care
by: Hanna L. Kleiboeker, et al.
Published: (2025)
by: Hanna L. Kleiboeker, et al.
Published: (2025)
Incidence and Risk Factors for Stroke After Combined Heart‐Kidney and Heart‐Liver Transplantation
by: Armaan F. Akbar, et al.
Published: (2024)
by: Armaan F. Akbar, et al.
Published: (2024)
Risk of Post‐Transplant Malignancy After Isolated Heart Transplant Among Adult Patients With Congenital Heart Disease
by: Orly Leiva, et al.
Published: (2025)
by: Orly Leiva, et al.
Published: (2025)
Transition From Intraoperative Vancomycin‐Piperacillin Tazobactam to Vancomycin‐Cefepime Does Not Change Acute Kidney Injury or Renal Recovery Outcomes in Patients Undergoing Heart Transplantation
by: Ashley L. Golbus, et al.
Published: (2025)
by: Ashley L. Golbus, et al.
Published: (2025)
Risk Factors and Outcomes of Invasive Candida Infections in Heart Transplant Recipients: A Case‐Control Study
by: Majd Alsoubani, et al.
Published: (2025)
by: Majd Alsoubani, et al.
Published: (2025)
Outcomes and Tolerability of Early Mammalian Target of Rapamycin Inhibitor Initiation for Renal Sparing in Heart Transplant Recipients
by: Avery Marcotte, et al.
Published: (2025)
by: Avery Marcotte, et al.
Published: (2025)
Cardio‐Renal‐Metabolic Outcomes Associated With the Use of GLP‐1 Receptor Agonists After Heart Transplantation
by: Elena M. Donald, et al.
Published: (2024)
by: Elena M. Donald, et al.
Published: (2024)
Time Well Spent: Clinical Predictors of Days Alive and Out of the Hospital After Heart Transplantation
by: Elissa Driggin, et al.
Published: (2025)
by: Elissa Driggin, et al.
Published: (2025)
Clinical Examples of the Additive Value of Absolute Quantification of Cell‐Free DNA After Heart Transplantation
by: Jens Böhmer, et al.
Published: (2024)
by: Jens Böhmer, et al.
Published: (2024)
The Nordic Experience of Pediatric Heart‐Lung Transplantation
by: Oscar van der Have, et al.
Published: (2026)
by: Oscar van der Have, et al.
Published: (2026)
Contemporary Cytomegalovirus (CMV) Infections in Low‐Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D−/R−): Time to Reexamine Donor CMV Serostatus
by: Madeleine R. Heldman, et al.
Published: (2024)
by: Madeleine R. Heldman, et al.
Published: (2024)
Trends, Clinical Characteristics, and Outcomes of Percutaneous Coronary Intervention in Liver Transplant Recipients
by: Song Peng Ang, et al.
Published: (2025)
by: Song Peng Ang, et al.
Published: (2025)
Increasing Multiorgan Heart Transplantations From Donation After Circulatory Death Donors in the United States
by: Shivank Madan, et al.
Published: (2024)
by: Shivank Madan, et al.
Published: (2024)
Kidney Allograft Outcomes of Dual‐Organ Heart Kidney Transplant Recipients Following Donation After Circulatory Determination of Death
by: Ananya Gorrai, et al.
Published: (2026)
by: Ananya Gorrai, et al.
Published: (2026)
Similar Items
-
Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
by: Vaisak O. Nair, et al.
Published: (2025) -
Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients
by: John‐Anthony Coppola, et al.
Published: (2025) -
Effects of Nighttime Procurement and Transplantation on Outcomes Following Heart Transplantation
by: Yeahwa Hong, et al.
Published: (2025) -
Impact of the Distance Between Patient Residency and Heart Transplant Center on Outcomes After Heart Transplantation
by: Waleed Ahmad, et al.
Published: (2024) -
Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
by: Suneri J. Amin, et al.
Published: (2025)